デフォルト表紙
市場調査レポート
商品コード
1396685

ポリエチレングリコール(PEG)の世界市場-2023年~2030年

Global Polyethylene Glycol Market - 2023-2030

出版日: | 発行: DataM Intelligence | ページ情報: 英文 217 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ポリエチレングリコール(PEG)の世界市場-2023年~2030年
出版日: 2023年12月15日
発行: DataM Intelligence
ページ情報: 英文 217 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要

世界のポリエチレングリコール(PEG)の市場規模は、2022年に43億米ドルに達し、2023年~2030年の予測期間中にCAGR6.4%で成長し、2030年には71億米ドルに達すると予測されています。

PEGは乳化剤、増粘剤であり、食品事業で使用される食品成分です。PEGを添加することで、保存期間が延長され、特定の食品の食感が改善されます。PEG市場は、顧客の嗜好の変化と世界の人口拡大がもたらした加工食品やインスタント食品への需要の高まりから恩恵を受けています。

PEGは、化粧品や個人衛生、スキンケア、ヘアケア製品の一般的な成分です。その強力な乳化性と保湿性が、化粧品組成物における使用の背景にあります。顧客の嗜好の変化や健康・美容動向に対する意識の高まりにより、PEG市場の成長はパーソナルケア業界の継続的な上昇と密接に関連しています。

アジア太平洋は、世界のポリエチレングリコール市場の1/3以上を占める成長地域の一つです。アジア太平洋の製造業は、さまざまな化学薬品、潤滑油、不凍組成物の基礎としてなど、PEGの工業用途を大いに活用しています。この地域、特に中国とインドにおける力強い工業の拡大が、様々な工業プロセスにおけるPEGの必要性を高めています。

力学

化粧品とパーソナルケア製品の需要拡大

パーソナルケアと化粧品分野は、世界のPEG市場の主要な促進要因です。乳化作用、保湿作用、増粘作用があるため、PEGはスキンケア、ヘアケア、トイレタリー製品の配合によく使われています。革新的で効果的なパーソナルケアソリューションに対する需要の増加は、身だしなみと美容基準の重視という顧客の嗜好の変化を反映しています。

例えば、Clariantは2022年、中国恵州市の大亜湾にあるケアケミカルズ施設を8000万スイスフラン(9,105万米ドル)を投じて拡張し、工業用途、医薬品、パーソナルケア向けのサービスを向上させる予定です。この拡張により、新しい品目を提供し、現在の品目の生産能力を向上させます。ダヤベイ工場は、ポリエチレングリコール(Polyglykol 3350)のGMP認証を取得した中国初の原薬メーカーとなり、注目すべきマイルストーンを達成しました。

製薬業界の成長

製薬業界の継続的な成長は、世界のポリエチレングリコール(PEG)市場を牽引する主な要因の一つです。PEGは薬物分布を改善し、一部の薬剤をより溶けやすくするため、医薬製剤には不可欠です。PEGは、高齢化、医療費の上昇、創薬の進歩などの理由により製薬業界が成長するにつれて需要が高まっています。

例えば、Croda Inc.は2021年に医薬品添加剤施設を拡張し、テープカットを行っています。ミルホールの最新の拡張は、固形経口剤、外用剤、生物製剤、ワクチンなど、さまざまな医療用途に不可欠な高純度医薬品原料の生産に特化します。この戦略的な工場拡張により、ミルホールの製造能力はほぼ倍増し、Croda Inc.のスーパーリファインブランドに属するこれらの高度な原料の製造が可能になります。

規制と環境問題

環境への影響に対する関心と懸念の高まりは、ポリエチレングリコール(PEG)の世界市場を制限する大きな要因の一つです。従来のPEGメーカーは石油化学資源を頻繁に使用しており、これが環境問題を悪化させています。生産工程で発生する排出物や廃棄物により、持続可能性や生態系への影響が懸念されています。

環境意識が高まり、規則が厳しくなるにつれて、この分野はより持続可能な方法を導入する必要に迫られています。製造業者は、バイオベースのPEGの必要性と厳しい環境基準を遵守する必要性から、コスト高につながるかもしれない困難を抱えています。この問題は、製造工程にも影響を及ぼす可能性があります。

有機代替品の入手可能性

オーガニックな治療法を求める動きにより、長期的な病気に対する自然な治療法を提供する医薬品への需要が高まっています。便秘は人生のどの段階でも発症する可能性がありますが、慢性化は主に高齢者に影響します。この病気を治療する場合、高齢者には通常さまざまな薬が処方されます。

しかし、アロパシー医薬品が過剰に大量に投与されると、多くの患者はこれらの薬に嫌悪感を覚え、代替療法に頼るようになります。アジア諸国では、高齢者にアーユルヴェーダ、ユナニ、中国伝統医学(TCM)などの代替療法が日常的に行われています。代替医療はその自然な成り立ちから、ある程度の影響を制限する可能性があるため、現在西洋諸国で人気が高まっています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 化粧品とパーソナルケア製品の需要拡大
      • 医薬品産業の成長
    • 抑制要因
      • 規制と環境問題
      • 有機代替品の入手可能性
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMIの見解

第6章 COVID-19分析

第7章 タイプ別

  • PEG 200
  • PEG 300
  • PEG 400
  • PEG 600
  • PEG 1,000
  • PEG 1,500
  • PEG 3,350
  • PEG 4,000
  • PEG 6,000
  • PEG 8,000
  • PEG 10,000
  • その他

第8章 形態別

  • 不透明液体
  • 粉末/フレーク
  • 白色ワックス状固体

第9章 包装タイプ別

  • ドラム
  • プラスチックボトル
  • カートン
  • その他

第10章 平均分子量別

  • 500g/mol未満
  • 500g/mol~1,000g/mol
  • 1,000g/mol~4,000g/mol
  • 4,000g/mol超

第11章 用途別

  • 医療
  • 工業
  • 化粧品・パーソナルケア
  • 建築・建設
  • プラスチック
  • 航空宇宙
  • その他

第12章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • ロシア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第13章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第14章 企業プロファイル

  • Dow Chemical Company
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
  • BASF SE
  • SABIC
  • Huntsman Corporation
  • Croda International Plc
  • Clariant AG
  • India Glycols Limited
  • Oxiteno
  • Ineos Group
  • LOTTE Chemical Corporation

第15章 付録

目次
Product Code: CH7574

Overview

Global Polyethylene Glycol (PEG) market reached US$ 4.3 billion in 2022 and is expected to reach US$ 7.1 billion by 2030, growing with a CAGR of 6.4% during the forecast period 2023-2030.

PEG is an emulsifier, thickening agent and food ingredient used in the food business. Its addition extends the shelf life and improves the texture of certain food goods. The PEG market has benefited from the rise in demand for processed and convenience foods brought forth by changing customer tastes and an expanding globally population.

PEG, is a common ingredient in makeup and personal hygiene, skincare and hair care products. Its potent emulsifying and moisturizing qualities are the reason behind its use in cosmetic compositions. Due to changing customer tastes and increased awareness of health and beauty trends, the PEG market's growth is closely linked to the personal care industry's continuous rise.

Asia-Pacific is among the growing regions in the global polyethylene glycol market covering more than 1/3rd of the market. The manufacturing industry in Asia-Pacific has made great use of PEG's industrial uses, including as a foundation for different chemicals, lubricants and antifreeze compositions. The strong industrial expansion in the region-especially in China and India-has raised the need for PEG in a variety of industrial processes.

Dynamics

Growing Demand for Cosmetics and Personal Care Products

The personal care and cosmetics sector is a major driver for the global PEG market. Due to its emulsifying, moisturizing and thickening characteristics, PEG is commonly incorporated into formulations for skincare, haircare and toiletry products. The increasing demand for personal care solutions that are both innovative and efficacious reflects shifting customer preferences, with a heightened emphasis on grooming and beauty standards.

For Instance, in 2022, Clariant is to expand its Care Chemicals facility in Daya Bay, Huizhou, China, with an investment of CHF 80 million (US$ 91.05 million), to improve services for industrial applications, pharmaceuticals and personal care. The expansion will provide new items and increase capacity for current ones. The Daya Bay factory has accomplished a noteworthy milestone by being the first API manufacturer in China to receive approval for a GMP certificate for polyethylene glycol, namely Polyglykol 3350.

Growth of the Pharmaceutical Industry

The pharmaceutical industry's continuous growth is one of the main factors driving the global polyethylene glycol (PEG) market. PEG is essential to pharmaceutical formulations because it improves drug distribution and makes some medications more soluble. PEG is in high demand as the pharmaceutical industry grows due to reasons such as an aging population, rising healthcare costs and advances in medication discovery.

For Instance, in 2021, Croda Inc. expanded its pharmaceutical excipients facility with a ribbon-cutting ceremony. The latest expansion in Mill Hall will be dedicated to the production of high-purity pharmaceutical ingredients crucial for a variety of healthcare applications, including solid oral doses, topicals, biologics and vaccines. The strategic plant expansion is poised to almost double Mill Hall's capacity for manufacturing these advanced ingredients, all of which fall under Croda's Super Refined brand.

Regulations and Environmental Concerns

The growing attention and worry about environmental effects is one of the major factors limiting the globally market for polyethylene glycol (PEG). Traditional PEG manufacturers frequently use petrochemical resources, which exacerbates environmental problems. There are concerns regarding sustainability and ecological effects due to the emissions and trash generated throughout the production process.

The sector is under pressure to implement more sustainable methods as environmental awareness grows and rules get stricter. Manufacturers have difficulties that might result in higher costs due to the need for bio-based PEG and the need to comply with strict environmental standards. The problems can affect their production processes.

Availability of Organic Substitutes

There is a growing demand for drugs that offer a natural remedy for long-term illnesses due to the movement toward organic treatments. Constipation can affect individuals at any stage of life, although the chronic form of the condition primarily affects the elderly. When treating this illness, elderly individuals are typically given a range of medications.

However, when allopathic pharmaceuticals are given in excessively high dosages, many patients develop an aversion to these medications and turn to alternative therapies. Elderly persons are routinely given alternative medical therapies including Ayurveda, Unani and Traditional Chinese Medicine (TCM) in several Asian nations. Because of its natural makeup, which might limit some effects, alternative medicine is currently growing in popularity in Western nations.

Segment Analysis

The global polyethylene glycol market is segmented based on type, form, packaging type, average molecular weight, application and region.

Rising PEG Use in Pharmaceutical and Medical Applications

The healthcare segment is among the growing regions in the global polyethylene glycol market covering more than 1/3rd of the market. The expansion of the global polyethylene glycol (PEG) market is significantly driven by the burgeoning healthcare industry. Due to its versatile applications, PEG is commonly employed in pharmaceutical and medicals.

Its pivotal role in the pharmaceutical sector involves enhancing the solubility and bioavailability of medications, making it a crucial component in various drug formulations. The sustained demand for PEG is propelled by the increasing prevalence of chronic diseases, a rising demand for advanced medication formulations and the continual expansion of the healthcare sector.

Geographical Penetration

Growing Personal Care and Cosmetics Products in Asia-Pacific

Asia-Pacific has been a dominant force in the global polyethylene glycol market is being driven by growing personal care and cosmetic items that are heavily consumed in the Asia-Pacific and this demand has been rising rapidly. PEG's popularity in skincare, hair care and toiletry products is attributed to its emulsifying and moisturizing attributes. The cosmetics industry is witnessing a rising demand for PEG, driven by heightened customer awareness of grooming and beauty standards.

The Asia-Pacific pharmaceutical industry has experienced significant expansion due to many causes including a growing and aging population, rising healthcare costs and an increase in the incidence of chronic illnesses. The demand for PEG in the region has been fueled by its utilization in pharmaceutical formulations, encompassing applications in drug delivery systems and serving as a solubilizing agent.

For Instance, in 2022, The expansion of BASF and SINOPEC's Verbund facility, run by BASF-YPC Co., Ltd., a 50/50 joint venture between the two corporations in Nanjing, began construction. The expansion aims to meet the increasing demand from different sectors in the Chinese market by adding a new tert-butyl acrylate plant and expanding the capabilities of other downstream chemical factories.

For Instance, in 2022, Mochida Pharmaceutical, Eisai and EA Pharma recently introduced "MOVICOL HD," an improved version of the polyethylene glycol medication "MOVICOL LD" for chronic constipation. Patients previously utilizing two sachets of "MOVICOL LD" may find savings and convenience from the new formulation, which doubles the active ingredients in each sachet. The update seeks to eliminate packaging waste, ease financial burden and expedite administration all of which are in keeping with the pharmaceutical industry's sustainability objectives.

COVID-19 Impact Analysis

The COVID-19 pandemic affected numerous businesses, including the globally polyethylene glycol (PEG) industry. Early on in the pandemic, extensive lockdowns, transportation interruptions and a drop in industrial activity had a big impact on PEG supply and demand dynamics. PEG production slowed significantly as a result of several manufacturing facilities having to temporarily close or operate at reduced capacity to adhere to health and safety regulations.

The pandemic also affected PEG's supply chain indirectly as border closures and other limitations made international logistics difficult. The flow of raw materials and completed items was hampered by delays in transportation and rising expenses, which changed the dynamics of the market as a whole. The demand for PEG in a variety of end-use sectors was also impacted by changes in consumer behavior during the epidemic and economic uncertainty.

Companies had to reassess the robustness of their supply chains and adjust to the changing market conditions as a result of the COVID-19 disruptions. Some PEG market sectors showed resilience and even development as the crisis developed, particularly in applications linked to healthcare, personal care and pharmaceuticals. The pandemic highlighted the significance of specific chemical molecules, like as PEG, in vital sectors.

In addition to persistent difficulties, the PEG market began to rebound as businesses adjusted to the new normal, put safety measures in place and addressed changes in consumer preferences brought on by the prolonged health crisis. As the world economy heals and adjusts to post-pandemic conditions, the pandemic's long-term impacts on the PEG market will keep developing.

Russia-Ukraine War Impact Analysis

The global market for polyethylene glycol may be affected by a war between Russia and Ukraine in some ways. Initially, both Russia and Ukraine were major participants in the petrochemical sector, helping to provide essential PEG raw materials. Any hiccups in the manufacturing or supply chain of these raw materials like ethylene oxide could result in shortages and affect the market's total supply of PEG. The can lead to higher costs and unpredictability in the supply chain for businesses globally.

The region's geopolitical tensions might cause more general economic uncertainty, which would affect investor confidence and market stability. The petrochemical sector, which produces PEG, is heavily reliant on a healthy economy. Increased demand, fluctuating currency prices and changed trade dynamics might all add to the volatility of the market.

Policy related to commerce and regulations may be impacted by the dispute. The international commerce of PEG and related products may be impacted by changes in trade agreements, import/export laws and penalties brought about by changes in geopolitical relationships. To negotiate the shifting geopolitical landscape, manufacturers may need to change their business strategies and supply networks to new trade circumstances.

By Type

  • PEG 200
  • PEG 300
  • PEG 400
  • PEG 600
  • PEG 1000
  • PEG 1500
  • PEG 3350
  • PEG 4000
  • PEG 6000
  • PEG 8000
  • PEG 10000
  • Others

By Form

  • Opaque Liquid
  • Powder/Flakes
  • White Waxy Solid

By Packaging Type

  • Drums
  • Plastic Bottles
  • Bags
  • Cartons
  • Others

By Average Molecular Weight

  • Less than 500g/mol
  • 500g/mol to 1000g/mol
  • 1000g/mol to 4000g/mol
  • More than 4000g/mol

By Application

  • Healthcare
  • Industrial
  • Cosmetics/Personal Care
  • Building and Construction
  • Plastics
  • Aerospace
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • On October 26, 2021, Camber Consumer Care introduced four new over-the-counter products: Loratadine Oral Solution, Polyethylene Glycol Powder, Fexofenadine 60 mg and Loperamide Hydrochloride & Simethicone. The firm currently helps a wide spectrum of patients by providing generic over-the-counter (OTC) medications in different strengths and amounts for allergy, pain and gastrointestinal relief.
  • On March 24, 2022, Rabigh Refining and Petrochemical Co. agreed with Gulf Cryo to implement a project for capturing CO2 emissions from the monoethylene glycol (MEG) plant at the Petro Rabigh industrial complex. The Saudi petrochemical company is set to initiate the project in August 2022, with trial operations anticipated by 2023. The facility marks a significant milestone as the first CO2-capturing plant in the Western Region of Saudi Arabia.

Competitive Landscape

The major global players in the market include: Dow Chemical Company, BASF SE, SABIC, Huntsman Corporation, Croda International Plc, Clariant AG, India Glycols Limited, Oxiteno, Ineos Group and LOTTE Chemical Corporation.

Why Purchase the Report?

  • To visualize the global polyethylene glycol market segmentation based on type, form, packaging type, average molecular weight, application and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of polyethylene glycol market --level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Type mapping available in Excel consisting of key Types of all the major players.

The global polyethylene glycol market report would provide approximately 77 tables, 93 figures and 217 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Form
  • 3.3. Snippet by Packaging Type
  • 3.4. Snippet by Average Molecular Weight
  • 3.5. Snippet by Application
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Demand for Cosmetics and Personal Care Products
      • 4.1.1.2. Growth of the Pharmaceutical Industry
    • 4.1.2. Restraints
      • 4.1.2.1. Regulations and Environmental Concerns
      • 4.1.2.2. Availability of Organic Substitutes
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. PEG 200*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. PEG 300
  • 7.4. PEG 400
  • 7.5. PEG 600
  • 7.6. PEG 1000
  • 7.7. PEG 1500
  • 7.8. PEG 3350
  • 7.9. PEG 4000
  • 7.10. PEG 6000
  • 7.11. PEG 8000
  • 7.12. PEG 10000
  • 7.13. Others

8. By Form

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2. Market Attractiveness Index, By Form
  • 8.2. Opaque Liquid*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Powder/Flakes
  • 8.4. White Waxy Solid

9. By Packaging Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 9.1.2. Market Attractiveness Index, By Packaging Type
  • 9.2. Drums*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Plastic Bottles
  • 9.4. Bags
  • 9.5. Cartons
  • 9.6. Others

10. By Average Molecular Weight

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Average Molecular Weight
    • 10.1.2. Market Attractiveness Index, By Average Molecular Weight
  • 10.2. Less than 500g/mol*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. 500g/mol to 1000g/mol
  • 10.4. 1000g/mol to 4000g/mol
  • 10.5. More than 4000g/mol

11. By Application

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.1.2. Market Attractiveness Index, By Application
  • 11.2. Healthcare*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Industrial
  • 11.4. Cosmetics/Personal Care
  • 11.5. Building & Construction
  • 11.6. Plastics
  • 11.7. Aerospace
  • 11.8. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Average Molecular Weight
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Average Molecular Weight
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. UK
      • 12.3.8.3. France
      • 12.3.8.4. Russia
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Average Molecular Weight
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Average Molecular Weight
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Average Molecular Weight
    • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. Dow Chemical Company*
    • 14.1.1. Company Overview
    • 14.1.2. Type Portfolio and Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. BASF SE
  • 14.3. SABIC
  • 14.4. Huntsman Corporation
  • 14.5. Croda International Plc
  • 14.6. Clariant AG
  • 14.7. India Glycols Limited
  • 14.8. Oxiteno
  • 14.9. Ineos Group
  • 14.10. LOTTE Chemical Corporation

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us